United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market Research Report Forecast 2017-2021
- SPI1281745
- 133 Pages
- June 2017
- Healthcare
This report provides comprehensive analysis of
Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs
The Major players reported in the market include:
Bayer (DE)
Novacap (FR)
Abbott
Pfizer Inc
Geri-Care Pharmaceuticals
Perrigo Company
Kopran Ltd.
Merck Sharp & Dohme Corp.
Sun Pharmaceutical Industries Ltd
...
United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market: Product Segment Analysis
Type 1
Type 2
Type 3
United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market: Application Segment Analysis
Back pain treatment
Osteoarthritis treatment
Other disease treatment
Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
Table Of Contents
United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market Research Report Forecast 2017-2021
Chapter 1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
1.1 Product Overview and Scope of Non-steroidal Anti-inflammatory Drugs (NSAID) Ma...
1.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segmentation by Type
1.2.1 United States Production Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type in 2015
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segmentation by Application
1.3.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Market Share by Application in 2015
1.3.2 Back pain treatment
1.3.3 Osteoarthritis treatment
1.3.4 Other disease treatment
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Non-steroidal Anti-inflammatory Drugs (NSAID) (2011-2021)
Chapter 2 United States Economic Impact on Non-steroidal Anti-inflammatory Drugs (NSAID) Industry
2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend
Chapter 3 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competition by Manufacturers
3.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Production and Share by Manufacturers (2015 and 2016)
3.2 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base Distribution, Production Area and Product Type
3.5 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competitive Situation and Trends
3.5.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration Rate
3.5.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
Chapter 4 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Revenue (Value), Price Trend by Type
4.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Production and Market Share by Type (2012-2017)
4.2 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share by Type (2012-2017)
4.3 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2012-2017)
4.4 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Production Growth by Type (2012-2017)
Chapter 5 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis by Application
5.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption and Market Share by Application (2012-2017)
5.2 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
5.3.1 Potential Applications
5.3.2 Emerging Markets/Countries
Chapter 6 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Analysis
6.1 Bayer (DE)
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Product Type, Application and Specification
6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Business Overview
6.2 Novacap (FR)
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Product Type, Application and Specification
6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Business Overview
6.3 Abbott
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Product Type, Application and Specification
6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Business Overview
6.4 Pfizer Inc
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Product Type, Application and Specification
6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Business Overview
6.5 Geri-Care Pharmaceuticals
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Product Type, Application and Specification
6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Business Overview
6.6 Perrigo Company
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.7 Kopran Ltd.
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Product Type, Application and Specification
6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Business Overview
6.8 Merck Sharp & Dohme Corp.
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.9 Sun Pharmaceutical Industries Ltd
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Product Type, Application and Specification
6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Business Overview
…
Chapter 7 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Cost Analysis
7.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) Ma...
Chapter 8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Non-steroidal Anti-inflammatory Drugs (NSAID) Major Manufacturers in 2015
8.4 Downstream Buyers
Chapter 9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
Chapter 10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
Chapter 11 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast (2017-2021)
11.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Revenue Forecast (2017-2021)
11.2 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Production Forecast by Type (2017-2021)
11.4 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Forecast by Application (2017-2021)
11.5 Non-steroidal Anti-inflammatory Drugs (NSAID) Price Forecast (2017-2021)
Chapter 12 Appendix
Table Classification of Non-steroidal Anti-inflammatory Drugs (NSAID) Ma...
Figure United States Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type in 2015
Table Application of Non-steroidal Anti-inflammatory Drugs (NSAID) Ma...
Figure United States Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application in 2015
Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2011-2021)
Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2011-2021)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales of Key Manufacturers (2015 and 2016)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers
Figure 2016 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers (2015 and 2016)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers
Table 2016 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers
Table United States Market Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price of Key Manufacturers in 2015
Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share of Top 3 Manufacturers
Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share of Top 5 Manufacturers
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2012-2017)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Type (2012-2017)
Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type in 2015
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share by Type (2012-2017)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2012-2017)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2012-2017)
Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Type (2012-2017)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2012-2017)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2012-2017)
Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application in 2015
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Application (2012-2017)
Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Application (2012-2017)
Table Bayer (DE) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer (DE) Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer (DE) Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (2012-2017)
Table Novacap (FR) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novacap (FR) Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Revenue, Price and Gross Margin (2012-2017)
Table Novacap (FR) Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (2012-2017)
Table Abbott Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbott Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (2012-2017)
Table Pfizer Inc Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Inc Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Inc Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (2012-2017)
Table Geri-Care Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Revenue, Price and Gross Margin (2012-2017)
Table Geri-Care Pharmaceuticals Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (2012-2017)
Table Perrigo Company Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Perrigo Company Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Revenue, Price and Gross Margin (2012-2017)
Table Perrigo Company Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (2012-2017)
Table Kopran Ltd. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Kopran Ltd. Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Revenue, Price and Gross Margin (2012-2017)
Table Kopran Ltd. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (2012-2017)
Table Merck Sharp & Dohme Corp. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck Sharp & Dohme Corp. Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Revenue, Price and Gross Margin (2012-2017)
Table Merck Sharp & Dohme Corp. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (2012-2017)
Table Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sun Pharmaceutical Industries Ltd Non-steroidal Anti-inflammatory Drugs (NSAID) Production, Revenue, Price and Gross Margin (2012-2017)
Table Sun Pharmaceutical Industries Ltd Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-steroidal Anti-inflammatory Drugs (NSAID) Ma...
Figure Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) Ma...
Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain Analysis
Table Raw Materials Sources of Non-steroidal Anti-inflammatory Drugs (NSAID) Major Manufacturers in 2015
Table Major Buyers of Non-steroidal Anti-inflammatory Drugs (NSAID) Ma...
Table Distributors/Traders List
Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Production and Growth Rate Forecast (2017-2021)
Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate Forecast (2017-2021)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Production Forecast by Type (2017-2021)
Table United States Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Forecast by Application (2017-2021)
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
